| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Quart Barry D is a Chief Executive Officer at HRTX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 16 sales.
Our model assigns Quart Barry D a below-average insider score of 41/100, based on 10 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -48.8%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 13,099 | $50.10 | $656,259.90 | -51.1% | +18.0% | - | |
| Apr 6, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 6,901 | $50.00 | $345,050.00 | -35.5% | +26.7% | - | |
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 2,800 | $45.00 | $126,000.00 | -18.2% | +32.2% | - | |
| Feb 4, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 15,960 | $45.22 | $721,634.60 | -56.0% | +30.4% | - | |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 20,129 | $41.51 | $835,554.79 | -61.6% | +11.9% | - | |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 27,448 | $30.35 | $833,001.36 | -68.6% | +22.0% | +70.7% | |
| Nov 29, 2022 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 21,959 | $16.15 | $354,637.85 | -100% | -17.2% | -1.7% | |
| Oct 3, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Buy | 4,571 | $17.50 | $79,992.50 | +5.1% | - | - | |
| Jun 21, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sale+OE | 50,000 | $39.05 | $1,952,500.00 | -41.8% | - | - | |
| Mar 19, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sale+OE | 100,000 | $29.75 | $2,975,000.00 | -59.5% | - | - |